The pre-analytical processing of blood samples for detecting biomarkers on protein microarrays

Journal of Immunological Methods

Volumn 418, Issue , 2015, Pages 39-51

  Rosskopf, Sandra ^a   Gyurján, István ^a   Soldo, Regina ^a   Luna Coronell, Johana A ^a   Vierlinger, Klemens ^a   Singer, Christian F ^b   Rappaport, Christine ^b   Pecha, Nina ^b   Weinhaeusel, Andreas ^a  

^a AIT AUSTRIAN INSTITUTE OF TECHNOLOGY   (Austria)

^b UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

Author keywords

Biomarker; DIRAGs; Immune proteomics; Immunoglobulin G; Pre analytics; Protein microarray

Indexed keywords

ANTIBODY; ANTIGEN; AUTOANTIBODY; BIOLOGICAL MARKER; IMMUNOGLOBULIN G; MATRIX PROTEIN;

ARTICLE; BLOOD SAMPLING; CENTRIFUGATION; FEMALE; HUMAN; PLASMA; PRIORITY JOURNAL; PROTEIN MICROARRAY; SAMPLE; ANALYSIS; BLOOD; IMMUNOLOGY; ISOLATION AND PURIFICATION; PROCEDURES; REPRODUCIBILITY;

ANALYTIC SAMPLE PREPARATION METHODS; BIOLOGICAL MARKERS; BLOOD SPECIMEN COLLECTION; FEMALE; HUMANS; IMMUNOGLOBULIN G; PROTEIN ARRAY ANALYSIS; REPRODUCIBILITY OF RESULTS;

EID: 84930336859     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2015.01.009     Document Type: Article

References (38)

1. Anderson, K.S., Ramachandran, N., Wong, J., Raphael, J.V., Hainsworth, E., Demirkan, G., Cramer, D., Aronzon, D., Hodi, F.S., Harris, L., Logvinenko, T., LaBaer, J., Application of protein microarrays for multiplexed detection of antibodies to tumor antigens in breast cancer. J. Proteome Res., 7, 2008, 1490, 10.1021/pr700804c.
2. Anderson, K.S., Sibani, S., Wallstrom, G., Qiu, J., Mendoza, E.A., Raphael, J., Hainsworth, E., Montor, W.R., Wong, J., Park, J.G., Lokko, N., Logvinenko, T., Ramachandran, N., Godwin, A.K., Marks, J., Engstrom, P., LaBaer, J., A protein microarray signature of autoantibody biomarkers for the early detection of breast cancer. J. Proteome Res., 10, 2011, 85, 10.1021/pr100686b.
3. Babel, I., Barderas, R., Díaz-Uriarte, R., Martínez-Torrecuadrada, J.L., Sánchez-Carbayo, M., Casal, J.I., Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays. Mol. Cell. Proteomics, 8, 2009, 2382, 10.1074/mcp. M800596-MCP200.
4. Barderas, R., Babel, I., Díaz-Uriarte, R., Moreno, V., Suárez, A., Bonilla, F., Villar-Vázquez, R., Capellá, G., Casal, J.I., An optimized predictor panel for colorectal cancer diagnosis based on the combination of tumor-associated antigens obtained from protein and phage microarrays. J. Proteome, 75, 2012, 4647, 10.1016/j.jprot.2012.03.004.
5. Bracci, P.M., Zhou, M., Young, S., Wiemels, J., Serum autoantibodies to pancreatic cancer antigens as biomarkers of pancreatic cancer in a San Francisco Bay Area case–control study. Cancer, 118, 2012, 5384, 10.1002/cncr.27538.
6. Brandt, B., Griwatz, C., Two-layer buoyant density centrifugation gradient for enrichment of prostate-derived cells and cell clusters from peripheral blood. Clin. Chem., 42, 1996, 1881.
7. Büssow, K., Cahill, D., Nietfeld, W., Bancroft, D., Scherzinger, E., Lehrach, H., Walter, G., A method for global protein expression and antibody screening on high-density filters of an arrayed cDNA library. Nucl. Acids Res., 26, 1998, 5007, 10.1093/nar/26.21.5007.
8. Correia, I.R., Stability of IgG isotypes in serum. MAbs, 2, 2010, 221.
9. Dati, F., Schumann, G., Thomas, L., Aguzzi, F., Baudner, S., Bienvenu, J., Blaabjerg, O., Blirup-Jensen, S., Carlström, A., Petersen, P.H., Johnson, A.M., Milford-Ward, A., Ritchie, R.F., Svendsen, P.J., Whicher, J., Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC/BCR/CAP Reference Material (CRM 470). International Federation of Clinical Chemistry.Community Bureau of Reference of the Commission of the European Communities. College of American Pathologists. Eur. J. Clin. Chem. Clin. Biochem., 34(6), 1996, 517.
10. Firestone, G.L., Winguth, S.D., Immunoprecipitation of proteins. Methods Enzymol., 182, 1990, 688.
11. Griffiths, J., The way of the array. Anal. Chem., 79, 2007, 8833, 10.1021/ac071993n.
12. Gunawardana, C.G., Diamandis, E.P., High throughput proteomic strategies for identifying tumour-associated antigens. Cancer Lett., 249, 2007, 110, 10.1016/j.canlet.2007.01.002.
13. Haab, B.B., Geierstanger, B.H., Michailidis, G., Vitzthum, F., Forrester, S., Okon, R., Saviranta, P., Brinker, A., Sorette, M., Perlee, L., Suresh, S., Drwal, G., Adkins, J.N., Omenn, G.S., Immunoassay and antibody microarray analysis of the HUPO Plasma Proteome Project reference specimens: systematic variation between sample types and calibration of mass spectrometry data. Proteomics, 5, 2005, 3278, 10.1002/pmic.200401276.
14. Janeway, C.A., Travers, P. Jr., Walport, M., Shlomchik, M.J., Immunobiology. 5th edition, 2001, The Immune System in Health and Disease. New York, Garland Science.
15. Junqueira, L.C.U., Carneiro, J., Basic Histology: Text and Atlas. 2005, McGraw-Hill Professional Publishing.
16. Lippi, G., Guidi, G.C., Mattiuzzi, C., Plebani, M., Preanalytical variability: the dark side of the moon in laboratory testing. Clin. Chem. Lab. Med.: CCLM/FESCC, 44, 2006, 358, 10.1515/CCLM.2006.073.
17. Lu, H., Goodell, V., Disis, M.L., Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer. J. Proteome Res., 7, 2008, 1388, 10.1021/pr700818f.
18. Luna Coronell, J.A., Syed, P., Sergelen, K., Gyurján, I., Weinhäusel, A., The current status of cancer biomarker research using tumour-associated antigens for minimal invasive and early cancer diagnostics. J. Proteome, 76, 2012, 102, 10.1016/j.jprot.2012.07.022 (Spec No).
19. Massoner, P., Lueking, A., Goehler, H., Höpfner, A., Kowald, A., Kugler, K.G., Amersdorfer, P., Horninger, W., Bartsch, G., Schulz-Knappe, P., Klocker, H., Serum-autoantibodies for discovery of prostate cancer specific biomarkers. Prostate, 72, 2012, 427, 10.1002/pros.21444.
20. Murphy, M.A., O'Leary, J.J., Cahill, D.J., Assessment of the humoral immune response to cancer. J. Proteome, 75, 2012, 4573, 10.1016/j.jprot.2012.01.021.
21. Nahtman, T., Jernberg, A., Mahdavifar, S., Zerweck, J., Schutkowski, M., Maeurer, M., Reilly, M., Validation of peptide epitope microarray experiments and extraction of quality data. J. Immunol. Methods, 328, 2007, 1, 10.1016/j.jim.2007.07.015.
22. Neumann, E.J., Bonistalli, K.N., Effect of blood sample handling post-collection on Erysipelothrix rhusiopathiae antibody titres. Vet. J., 180, 2009, 325, 10.1016/j.tvjl.2008.07.020.
23. O'Keane, M.P., Cunningham, S.K., Evaluation of three different specimen types (serum, plasma lithium heparin and serum gel separator) for analysis of certain analytes: clinical significance of differences in results and efficiency in use. Clin. Chem. Lab. Med., 44, 2006, 662, 10.1515/CCLM.2006.099.
24. Pollard, K.M., (eds.) Autoantibodies and Autoimmunity: Molecular Mechanisms in Health and Disease, 2006.
25. Preininger, C., Bodrossy, L., Sauer, U., Pichler, R., Weilharter, A., ARChip Epoxy and ARChip UV for covalent on-chip immobilization of pmoA gene-specific oligonucleotides. Anal. Biochem., 330, 2004, 29.
26. Rauch, P., Zellmer, A., Dankbar, N., Specht, C., Sperling, D., Optimisation of Assays: Interference in Immunoassays — Recognize and Avoid. 2009.
27. Shoenfeld, Yehuda, Gershwin, Eric M., (eds.) List of contributors Cancer and Autoimmunity, 2000, Elsevier, Amsterdam, ix.
28. Simon, R., Radmacher, M.D., Dobbin, K., McShane, L.M., Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. J. Natl. Cancer Inst., 95, 2003, 14, 10.1093/jnci/95.1.14.
29. Simon, R., Lam, A., Li, M.-C., Ngan, M., Menenzes, S., Zhao, Y., Analysis of gene expression data using BRB-ArrayTools. Cancer Informat, 3, 2007, 11.
30. Stafford, P., Johnston, S., Microarray technology displays the complexities of the humoral immune response. Expert. Rev. Mol. Diagn., 11, 2011, 5, 10.1586/erm.10.113.
31. Stempfer, R., Syed, P., Vierlinger, K., Pichler, R., Meese, E., Leidinger, P., Ludwig, N., Kriegner, A., Nöhammer, C., Weinhäusel, A., Tumour auto-antibody screening: performance of protein microarrays using SEREX derived antigens. BMC Cancer, 10, 2010, 627, 10.1186/1471-2407-10-627.
32. Syed, P., Vierlinger, K., Kriegner, A., Sergelen, K., Luna-Coronell, J., Rappaport-Fürhauser, C., Nöhammer, C., Singer, C.F., Weinhäusel, A., Evaluation of auto-antibody serum biomarkers for breast cancer screening and in silico analysis of sero-reactive proteins. J. Mol. Biochem. 1 (2012), 116–128.
33. Syed, P., Vierlinger, K., Kriegner, A., Sergelen, K., Luna-Coronell, J., Rappaport-Fürhauser, C., Nöhammer, C., Singer, C.F., Weinhäusel, A., Evaluation of auto-antibody serum biomarkers for breast cancer screening and in silico analysis of sero-reactive proteins. J. Mol. Biochem., 1, 2012, 116.
34. Tan, H.T., Low, J., Lim, S.G., Chung, M.C.M., Serum autoantibodies as biomarkers for early cancer detection. FEBS J., 276, 2009, 6880, 10.1111/j.1742-4658.2009.07396.x.
35. Tuck, M.K., Chan, D.W., Chia, D., Godwin, A.K., Grizzle, W.E., Krueger, K.E., Rom, W., Sanda, M., Sorbara, L., Stass, S., Wang, W., Brenner, D.E., Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group. J. Proteome Res., 8, 2009, 113, 10.1021/pr800545q.
36. Ullah, M.F., Aatif, M., The footprints of cancer development: cancer biomarkers. Cancer Treat. Rev., 35, 2009, 193, 10.1016/j.ctrv.2008.10.004.
37. Wild, D.G., Standardization and calibration. The Immunoassay Handbook, Third Ed., 2005, Elsevier Ltd, Oxford, 167.
38. Zhao, X., Qureshi, F., Eastman, P.S., Manning, W.C., Alexander, C., Robinson, W.H., Hesterberg, L.K., Pre-analytical effects of blood sampling and handling in quantitative immunoassays for rheumatoid arthritis. J. Immunol. Methods, 378, 2012, 72, 10.1016/j.jim.2012.02.007.